BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9070891)

  • 1. Adenovirus-mediated gene therapy of gastric carcinoma using cancer-specific gene expression in vivo.
    Tanaka T; Kanai F; Lan KH; Ohashi M; Shiratori Y; Yoshida Y; Hamada H; Omata M
    Biochem Biophys Res Commun; 1997 Feb; 231(3):775-9. PubMed ID: 9070891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenovirus-mediated prodrug gene therapy for carcinoembryonic antigen-producing human gastric carcinoma cells in vitro.
    Tanaka T; Kanai F; Okabe S; Yoshida Y; Wakimoto H; Hamada H; Shiratori Y; Lan K; Ishitobi M; Omata M
    Cancer Res; 1996 Mar; 56(6):1341-5. PubMed ID: 8640823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of the Cre recombinase/loxP system further enhances antitumor effects in cell type-specific gene therapy against carcinoembryonic antigen-producing cancer.
    Kijima T; Osaki T; Nishino K; Kumagai T; Funakoshi T; Goto H; Tachibana I; Tanio Y; Kishimoto T
    Cancer Res; 1999 Oct; 59(19):4906-11. PubMed ID: 10519403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo adenovirus-mediated prodrug gene therapy for carcinoembryonic antigen-producing pancreatic cancer.
    Ohashi M; Kanai F; Tanaka T; Lan KH; Shiratori Y; Komatsu Y; Kawabe T; Yoshida H; Hamada H; Omata M
    Jpn J Cancer Res; 1998 Apr; 89(4):457-62. PubMed ID: 9617353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor cell-specific transgene expression prevents liver toxicity of the adeno-HSVtk/GCV approach.
    Brand K; Löser P; Arnold W; Bartels T; Strauss M
    Gene Ther; 1998 Oct; 5(10):1363-71. PubMed ID: 9930342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptionally targeted in vivo gene therapy for carcinoembrionic antigen-producing adenocarcinoma.
    Konishi F; Maeda H; Yamanishi Y; Hiyama K; Ishioka S; Yamakido M
    Hiroshima J Med Sci; 1999 Sep; 48(3):79-89. PubMed ID: 10598410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of murine mammary carcinoma growth and metastasis by HSVtk/GCV gene therapy using in vivo electroporation.
    Shibata MA; Morimoto J; Otsuki Y
    Cancer Gene Ther; 2002 Jan; 9(1):16-27. PubMed ID: 11916241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of protamine to augment adenovirus-mediated cancer gene therapy.
    Lanuti M; Kouri CE; Force S; Chang M; Amin K; Xu K; Blair I; Kaiser L; Albelda S
    Gene Ther; 1999 Sep; 6(9):1600-10. PubMed ID: 10490770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A tandemly repeated thyroglobulin core promoter has potential to enhance efficacy for tissue-specific gene therapy for thyroid carcinomas.
    Takeda T; Yamazaki M; Minemura K; Imai Y; Inaba H; Suzuki S; Miyamoto T; Ichikawa K; Kakizawa T; Mori J; DeGroot LJ; Hashizume K
    Cancer Gene Ther; 2002 Oct; 9(10):864-74. PubMed ID: 12224028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo selective gene expression and therapy mediated by adenoviral vectors for human carcinoembryonic antigen-producing gastric carcinoma.
    Lan KH; Kanai F; Shiratori Y; Ohashi M; Tanaka T; Okudaira T; Yoshida Y; Hamada H; Omata M
    Cancer Res; 1997 Oct; 57(19):4279-84. PubMed ID: 9331089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinoembryonic antigen-specific suicide gene therapy of cytosine deaminase/5-fluorocytosine enhanced by the cre/loxP system in the orthotopic gastric carcinoma model.
    Ueda K; Iwahashi M; Nakamori M; Nakamura M; Matsuura I; Yamaue H; Tanimura H
    Cancer Res; 2001 Aug; 61(16):6158-62. PubMed ID: 11507067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-specific transcriptional targeting of suicide gene therapy.
    Qiao J; Doubrovin M; Sauter BV; Huang Y; Guo ZS; Balatoni J; Akhurst T; Blasberg RG; Tjuvajev JG; Chen SH; Woo SL
    Gene Ther; 2002 Feb; 9(3):168-75. PubMed ID: 11859419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus-mediated tissue-targeted expression of the HSVtk gene for the treatment of breast cancer.
    Anderson LM; Swaminathan S; Zackon I; Tajuddin AK; Thimmapaya B; Weitzman SA
    Gene Ther; 1999 May; 6(5):854-64. PubMed ID: 10505111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recombinant adenovirus vector-mediated herpes simplex virus thymidine kinase gene transfer followed by ganiciclovir administration effectively inhibits growth of human small-cell lung cancer in a murine xenotransplant model].
    Zhou JF; Chen G; Lu YP; Wang SX; Ma D
    Zhonghua Zhong Liu Za Zhi; 2004 Feb; 26(2):68-70. PubMed ID: 15059319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The telomerase reverse transcriptase promoter drives efficacious tumor suicide gene therapy while preventing hepatotoxicity encountered with constitutive promoters.
    Majumdar AS; Hughes DE; Lichtsteiner SP; Wang Z; Lebkowski JS; Vasserot AP
    Gene Ther; 2001 Apr; 8(7):568-78. PubMed ID: 11319624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
    Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
    Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E1A, E1B double-restricted replicative adenovirus at low dose greatly augments tumor-specific suicide gene therapy for gallbladder cancer.
    Fukuda K; Abei M; Ugai H; Kawashima R; Seo E; Wakayama M; Murata T; Endo S; Hamada H; Hyodo I; Yokoyama KK
    Cancer Gene Ther; 2009 Feb; 16(2):126-36. PubMed ID: 18818710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Midkine promoter-based adenoviral vector gene delivery for pediatric solid tumors.
    Adachi Y; Reynolds PN; Yamamoto M; Grizzle WE; Overturf K; Matsubara S; Muramatsu T; Curiel DT
    Cancer Res; 2000 Aug; 60(16):4305-10. PubMed ID: 10969765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing.
    Wiewrodt R; Amin K; Kiefer M; Jovanovic VP; Kapoor V; Force S; Chang M; Lanuti M; Black ME; Kaiser LR; Albelda SM
    Cancer Gene Ther; 2003 May; 10(5):353-64. PubMed ID: 12719705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinoids augment the bystander effect in vitro and in vivo in herpes simplex virus thymidine kinase/ganciclovir-mediated gene therapy.
    Park JY; Elshami AA; Amin K; Rizk N; Kaiser LR; Albelda SM
    Gene Ther; 1997 Sep; 4(9):909-17. PubMed ID: 9349427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.